Time-dependent prognostic improvement by late gadolinium enhancement in dilated cardiomyopathy

Siqi Tang1, Yuanwei Xu2, Yangjie Li2

  • 1Department of Internal Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.

Insights

Adding late gadolinium enhancement (LGE) to heart failure (HF) prediction models moderately improves long-term mortality prediction in dilated cardiomyopathy (DCM) patients. Short-term prediction accuracy was not significantly enhanced by LGE integration.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Heart Failure Research

Background:

  • Dilated cardiomyopathy (DCM) is a primary cause of heart failure (HF).
  • Current HF prediction models lack specific validation in DCM cohorts.
  • Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) is a known mortality predictor in DCM.

Purpose of the Study:

  • To externally validate existing HF prediction models in a DCM cohort.
  • To assess the incremental value of LGE in improving HF prediction accuracy in DCM patients.

Main Methods:

  • Single-center cohort study of 524 hospitalized DCM patients undergoing CMR.
  • External validation of five established HF models (SHFM, GISSI-HF, MAGGIC, BIOSTAT-CHF, PREDICT-HF).
  • Development of LGE-enhanced models integrating LGE characteristics (presence, location, pattern) with existing risk scores.

Main Results:

  • PREDICT-HF demonstrated the best discrimination among validated models (C-index 0.73).
  • Incorporating LGE (presence, location, pattern) significantly improved discrimination for 3- and 4-year predictions (P<0.05).
  • LGE integration did not enhance short-term (1- and 2-year) prediction accuracy.

Conclusions:

  • Existing clinical variable-based HF models offer moderate prediction in DCM.
  • LGE significantly enhances long-term mortality prediction in DCM patients.
  • LGE does not improve short-term HF prediction efficacy in this cohort.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
449
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
378
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
316